FDA Inspection 1108843 — Shore Institute For Reproductive Medicine, P.C.

Shore Institute For Reproductive Medicine, P.C. — FEI 3003945094

The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on Oct 24, 2019 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 24, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lakewood, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.